Skip to main content

Advertisement

SpringerLink
Log in

Clinical and Metabolic Effects of Biliopancreatic Diversion Persist After Reduction of the Gastric Pouch and Elongation of the Common Alimentary Tract. Preliminary Report in a Series of Patients with a 10-Year Follow-Up

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Biliopancreatic diversion (BPD) is a bariatric technique burdened, in some instances, by clinical evidence of malabsorption and malnutrition, and by intractable diarrhea.

Objective

The objective of this study was to assess metabolic and nutritional effects on patients undergoing BPD and BPD plus revisional surgery because of side effects.

Methods

Thirty-five consecutive BPD patients underwent revisional surgery (elongation of the common limb from 50 to 200 cm and reduction of the gastric pouch from 500 to 40 ml) after a median 48-month period [48.3 ± 9.17 months (mean ± SD)] and were observed for a total period of 116.2 ± 6.21 months; 88 patients only undergoing BPD (controls) were observed for 120 months.

Results

Revisional surgery significantly improved side effects of BPD, with resolution of clinical symptoms in most instances. After revisional surgery, patients had a further decrease of body weight. The effect on disappearance of diabetes mellitus (DM) was remarkable, with no difference between revisional surgery and BPD. Triglycerides and transaminases decreased in a similar way, while cholesterol levels differed significantly. Estimated glomerular filtration rate improved. Nutritional parameters were similarly affected.

Conclusion

This study suggests that it is possible to maintain the clinical and metabolic effects of BPD after a revisional procedure that leads to lesser malabsorption and to a greater restriction of the stomach. In particular, the positive effects on DM still persist after revisional surgery. This approach should be kept in mind in the presence of significant side effects due, inter alia, to excessive malabsorption.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Alvarez-Cordero R. Treatment of clinically severe obesity—a public health problem: introduction. World J Surg. 1998;22:905–6.

    Article  CAS  PubMed  Google Scholar 

  2. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.

    Article  CAS  PubMed  Google Scholar 

  3. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.

    Article  PubMed  Google Scholar 

  4. Keshishian A, Zahriya K, Willes EB. Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months. Obes Surg. 2005;15:1418–23.

    Article  PubMed  Google Scholar 

  5. Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg. 2007;17:176–84.

    Article  PubMed  Google Scholar 

  6. Aller R, Pacheco D, Izaola O, et al. Effect on liver enzymes of biliopancreatic diversion: 4 years of follow-up. Ann Nutr Metab. 2015;66:132–6.

    Article  CAS  PubMed  Google Scholar 

  7. Dixon JB, Bhathal PS, O'Brien PE. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg. 2006;16:1278–86.

    Article  PubMed  Google Scholar 

  8. Gastaldelli A, Perego L, Paganelli M, et al. Elevated concentrations of liver enzymes and ferritin identify a new phenotype of insulin resistance: effect of weight loss after gastric banding. Obes Surg. 2009;19:80–6.

    Article  PubMed  Google Scholar 

  9. Weiner RA. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. Dig Dis. 2010;28:274–9.

    Article  CAS  PubMed  Google Scholar 

  10. Hafeez S, Ahmed MH. Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? J Obes. 2013;2013:839275.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Burza MA, Romeo S, Kotronen A, et al. Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study. PLoS One. 2013;8(3):e60495.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Folini L, Veronelli A, Benetti A, et al. Liver steatosis (LS) evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity; effect of weight loss obtained with intragastric balloon gastric banding. Acta Diabetol. 2014;51:361–8.

    Article  CAS  PubMed  Google Scholar 

  13. Hassanian M, Al-Mulhim A, Al-Sabhan A, et al. The effect of bariatric surgeries on nonalcoholic fatty liver disease. Saudi J Gastroenterol. 2014;20:270–8.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Scopinaro N. Biliopancreatic diversion: mechanisms of action and long-term results. Obes Surg. 2006;16:683–9.

    Article  PubMed  Google Scholar 

  15. Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg. 1998;22:936–46.

    Article  CAS  PubMed  Google Scholar 

  16. Ceriani V, Pinna F, Lodi T, Gaffuri P. Revisional surgery: biliopancreatic diversion failure. In: M. Lucchese, N. Scopinaro (eds): Bariatric and Metabolic Mini-Invasive Surgery. Principles and Technical Aspects, Springer, 2015, pp 257–266.

  17. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl 1):S62–9.

    Article  PubMed Central  Google Scholar 

  18. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes?. Diabetes Care. 2009;32:2133–5.

  19. Levey AS, Coresh J, Greene T, et al. Chronic kidney disease epidemiology C. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–54.

    Article  CAS  PubMed  Google Scholar 

  20. Hakeam HA, O'Regan PJ, Salem AM, et al. Impact of laparoscopic sleeve gastrectomy on iron indices: 1 year follow-up. Obes Surg. 2009;19:1491–6.

    Article  PubMed  Google Scholar 

  21. Varma S, Baz W, Badine E, et al. Need for parenteral iron therapy after bariatric surgery. Surg Obes Relat Dis. 2008;4:715–9.

    Article  PubMed  Google Scholar 

  22. Obinwanne KM, Fredrickson KA, Mathiason MA, et al. Incidence, treatment, and outcomes of iron deficiency after laparoscopic Roux-en-Y gastric bypass: a 10-year analysis. J Am Coll Surg. 2014;218:246–52.

    Article  PubMed  Google Scholar 

  23. Ferrer R, Pardina E, Rossell J, et al. Haematological parameters and serum trace elements in “healthy” and “unhealthy” morbidly obese patients before and after gastric bypass. Clin Nutr. 2015;34:276–83.

    Article  CAS  PubMed  Google Scholar 

  24. Schuster DP, Teodorescu M, Mikami D, et al. Effect of bariatric surgery on normal and abnormal renal function. Surg Obes Relat Dis. 2011;7:459–64.

    Article  CAS  PubMed  Google Scholar 

  25. Agrawal V, Krause KR, Chengelis DL, et al. Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein. Surg Obes Relat Dis. 2009;5:20–6.

    Article  PubMed  Google Scholar 

  26. Iaconelli A, Panunzi S, De Gaetano A, et al. Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care. 2011;34:561–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Jose B, Ford S, Super P, et al. The effect of biliopancreatic diversion surgery on renal function—a retrospective study. Obes Surg. 2013;23:634–7.

    Article  PubMed  Google Scholar 

  28. Ruiz-Tovar J, Giner L, Sarro-Sobrin F, et al. Laparoscopic sleeve gastrectomy prevents the deterioration of renal function in morbidly obese patients over 40 years. Obes Surg. 2015;25:796–9.

    Article  PubMed  Google Scholar 

  29. Ballesteros-Pomar MD, González de Francisco T, Urioste-Fondo A, et al. Biliopancreatic diversion for severe obesity: long-term effectiveness and nutritional complications. Obes Surg. 2016;26:38–44.

    Article  PubMed  Google Scholar 

  30. Marceau P, Biron S, Marceau S, et al. Long-term metabolic outcomes 5 to 20 years after biliopancreatic diversion. Obes Surg. 2015;25:1584–93.

    Article  PubMed  Google Scholar 

  31. Thurnheer M, Bisang P, Ernst B, et al. A novel distal very long Roux-en Y gastric bypass (DVLRYGB) as a primary bariatric procedure—complication rates, weight loss, and nutritional/ metabolic changes in the first 355 patients. Obes Surg. 2012;22:1427–36.

    Article  PubMed  Google Scholar 

  32. Svanevik M, Risstad H, Hofsø D, et al. Perioperative outcomes of proximal and distal gastric bypass in patients with BMI ranged 50-60 kg/m2. A double-blind, randomized controlled trial. Obes Surg. 2015;25:1788–95.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Sugerman HJ, Kellum JM, DeMaria EJ. Conversion of proximal to distal gastric bypass for failed gastric bypass for superobesity. J Gastrointest Surg. 1997;1:517–24.

    Article  CAS  PubMed  Google Scholar 

  34. Brolin RE, LaMarca LB, Kenler HA, et al. Malabsorptive gastric bypass in patients with super-obesity. J Gastrointest Surg. 2002;6:195–203.

    Article  PubMed  Google Scholar 

  35. Ceriani V, Cetta F, Pinna F, et al. Abnormal calcium, 25(OH)vitamin D, and parathyroid hormone after biliopancreatic diversion; correction through elongation of the common tract and reduction of the gastric pouch. Surgery for Obesity and Related Diseases, Surg Obes Relat Dis. 2016;12:805–12.

    Article  PubMed  Google Scholar 

  36. Busetto L, Sbraccia P, Frittitta L, et al. The growing role of bariatric surgery in the management of type 2 diabetes: evidences and open questions. Obes Surg. 2011;21:1451–7.

    Article  PubMed  Google Scholar 

  37. Salehi M, D'Alessio DA. Effects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgery. Rev Endocr Metab Disord. 2014;15:171–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Frige' F, Laneri M, Veronelli A, et al. Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass. Nutr Metab Cardiovasc Dis. 2009;19:198–204.

    Article  PubMed  Google Scholar 

  39. Pontiroli AE, Laneri M, Veronelli A, et al. Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters. Cardiovasc Diabetol. 2009;8:37.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Benetti A, Del Puppo M, Crosignani A, et al. Cholesterol metabolism after bariatric surgery in grade 3 obesity: differences between malabsorptive and restrictive procedures. Diabetes Care. 2013;36:1443–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Currò G, Centorrino T, Cogliandolo A, et al. A clinical and nutritional comparison of biliopancreatic diversion performed with different common and alimentary channel lengths. Obes Surg. 2015;25:45–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto di Ricovero e Cura a Carattere Scientifico Multimedica, Milan, Italy

    Valerio Ceriani, Francesco Cetta, Tiziana Lodi & Ferdinando Pinna

  2. Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy

    Antonio E. Pontiroli

  3. Ospedale San Paolo, Via Antonio di Rudinì 8, 20142, Milan, Italy

    Antonio E. Pontiroli

Authors
  1. Valerio Ceriani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesco Cetta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tiziana Lodi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ferdinando Pinna
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Antonio E. Pontiroli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antonio E. Pontiroli.

Ethics declarations

The authors declare that they have no conflict of interest. Informed consent was obtained from all individual participants included in the study. There was no funding for this study. The paper is not based on a previous communication to a society or meeting.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ceriani, V., Cetta, F., Lodi, T. et al. Clinical and Metabolic Effects of Biliopancreatic Diversion Persist After Reduction of the Gastric Pouch and Elongation of the Common Alimentary Tract. Preliminary Report in a Series of Patients with a 10-Year Follow-Up. OBES SURG 27, 1493–1500 (2017). https://doi.org/10.1007/s11695-016-2479-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-016-2479-3

Keywords

Search

Navigation